✨ Trade Name Application and Psychotherapists Board Notice
NEW ZEALAND GAZETTE, No. 109 — 1 OCTOBER 2015
Trade Names:
Fortekor Plus 5mg pimobendan/10mg Benazepril HCl Tablets for Dogs
Fortekor Plus 1.25mg pimobendan/2.5mg benazepril HCl Tablets for Dogs
References: A11170, A11169
Active Ingredients and Concentrations:
Fortekor Plus 5mg pimobendan/10mg Benazepril HCl Tablets for Dogs
Fortekor Plus 1.25mg pimobendan/2.5mg benazepril HCl Tablets for Dogs
Formulation Type: Tablet
General Use Claim:
For treatment of congestive heart failure in dogs.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
a. must state in full the reasons for making the submission; and
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
a. where submissions on this application are to be sent; and
b. where requests for copies of the public information relating to the application can be sent; and
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Craig Cunningham, Novartis New Zealand Limited, 109 Carlton Gore Road, Newmarket, Auckland 1023.
Dated at Wellington this 29th day of September 2015.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).
2015-go5842
General Section
Notice of Scopes of Practice and Related Qualifications Prescribed by the Psychotherapists Board of Aotearoa New Zealand
Pursuant to sections 11 and 12 of the Health Practitioners Competence Assurance Act 2003 (“the Act”), the following notice is given.
Notice
- Title and commencement—(1) Notice of Scopes of Practice and Related Qualifications Prescribed by the Psychotherapists Board of Aotearoa New Zealand.
(2) This notice comes into force on 1 October 2015.
- Revocation—This notice revokes and replaces all previous scopes of practice and qualifications prescribed by the Psychotherapists Board of Aotearoa New Zealand.
62
Next Page →
NZ Gazette 2015, No 109
✨ LLM interpretation of page content
🌾 Notice of Application to Register Trade Name Products (Notice No. MPI 548)
🌾 Primary Industries & Resources29 September 2015
Trade Name, Application, Agricultural Compounds, Veterinary Medicines, Fortekor Plus, Pimobendan, Benazepril HCl
- MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries
🏥 Notice of Scopes of Practice and Related Qualifications Prescribed by the Psychotherapists Board of Aotearoa New Zealand
🏥 Health & Social WelfarePsychotherapists, Scopes of Practice, Qualifications, Health Practitioners Competence Assurance Act 2003